Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.71 USD
16.39%
Market Closed
Updated:
May 21, 2024
Atara Biotherapeutics Inc
Other Current Liabilities
|
Atara Biotherapeutics Inc
Other Current Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Other Current Liabilities
$123.2m
|
CAGR 3-Years
42%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
149%
|
CAGR 5-Years
406%
|
CAGR 10-Years
26%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Liabilities
$648.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Liabilities
$516.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
See Also
What is Atara Biotherapeutics Inc's Other Current Liabilities?
Other Current Liabilities
123.2m
USD
123.2m
USD
Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Other Current Liabilities amounts to 123.2m USD.
What is Atara Biotherapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
96%
96%
Over the last year, the Other Current Liabilities growth was 1 144%. The average annual Other Current Liabilities growth rates for Atara Biotherapeutics Inc have been 42% over the past three years , 96% over the past five years .
You don't have any saved screeners yet
